-
Electronic (PDF)
-
Hard Copy
-
CD ROM
-
Site License
-
Enterprisewide
Global Funding of Nanotechnologies - 2011 Edition
Cientifica Ltd, September 2011, Pages: 82
In the last 11 years, governments around the world have invested more than US$67 billion in funding nanotechnology research. While some funding programs are mature and concentrating on translational research, others are still at an early stage requiring large purchases of infrastructure, from instruments to buildings and services.
Cientifica has been tracking public funding of nanotechnologies for ten years, and its unrivalled connections with academics and funding agencies make this report, the most accurate available.
The report also predicts government funding of nanotechnologies to 2015, using the latest information and taking the current economic climate into account.
The report contains detailed breakdown and analyses of funding in the major economies of the Americas, Asia, EMEA and RoW including:
- Method of Distribution
- Areas of Distribution
- Infrastructure Funding
- Timescale for Funding
- Size of Funding Investments
This report looks at:
- Changes to funding figures going forward based on the current economic climate
- The most noticeable changes in policy or focus for nanotech funding in the current environment
- Changes in the amount of funding allocated to infrastructure/equipment based on plans going forward
- Key/major infrastructure initiatives; e.g. new nanotech centers, new initiatives
- Flagship programs that are in the works/early phase
- Provide indices for emerging technology exploitation, and a nanotechnology impact factor for each featured country.
Finally, using indicators from various sources such as WEF, OECD and IMF, we have calculated two key indices for each country as a measure of which countries are most well equipped to translate research into the economy:
- Emerging technology exploitation index (EEI)
Every year Cientifica undertakes one of the world's most exhaustive searches into the global funding of nanotechnologies in order to identify not only where the dollars, euros and yen are being spent, but also to gain an unique insight into the trends shaping tomorrow's applications.
For the 2011 report we have also integrated data from the World Economic Forum's annual Global Competitiveness Report in order to gain insights into how well various countries are able to capitalise on their investment in research.
Key Findings
- With US government funding of nanotechnology receding slightly in 2011, Purchasing Power Parity (PPP) estimates indicate that for the first time, China will spend more than the US to fund nanotechnology.
- In the last 11 years, governments around the world have invested more than US$67.5 billion in nanotechnology funding. When corporate research and various other forms of private funding are taken into account, nearly a quarter of a trillion dollars will have been invested in nanotechnology by 2015.
- Corporate research and private funding were thought to have surpassed government funding figures as far back as 2004. But this year, according to Cientifica's estimates, in PPP terms China will spend US$2.25 billion in nanotechnology research while the US will spend US$2.18 billion. In real dollar terms, adjusted for currency exchange rates, China is only spending about US$1.3 billion to the US's $2.18 billion.
- This appears to be a temporary hiccup in US dominance in public funding of nanotechnology with the US again taking the lead next year even in PPP terms, spending $2.46 billion with China allotting $2.2 billion.
- Cientifica's index of countries' ability to take advantage of emerging technologies indicates the US, Germany, Taiwan and Japan have the combination of academic excellence, technology-hungry companies, skilled workforces and the availability of early stage capital to ensure effective technology transfer.
- When combined with levels of nanotechnology funding, the US is still the place to be, although China and Russia are increasingly attractive. The UK and UK and India struggle at the bottom of the league.
- A white paper is also available giving an overview of the key numbers, which we believe to be the most accurate available anywhere.
INTRODUCTION
Summary of Funding in last decade
Timescale for Funding
Summary of Findings
AMERICAS
UNITED STATES OF AMERICA
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
Emerging technology index rank
Nanotech Impact factor
CANADA
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments ?
Flagship programs that are in the works/early phase
Emerging technology index rank
Nanotech Impact factor
ASIA-PACIFIC
AUSTRALIA
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
Emerging technology index rank
Nanotech Impact factor
CHINA
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
INDIA
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
Emerging technology index rank
Nanotech Impact factor
Japan
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
SOUTH KOREA
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
Emerging technology index rank
Nanotech Impact factor
TAIWAN
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
EMEA
EC
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
Emerging technology index rank
Nanotech Impact factor
GERMANY
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
Emerging technology index rank
Nanotech Impact factor
ISRAEL
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
Scientific innovation Index rank
Emerging technology index rank
Nanotech Impact factor
RUSSIA
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
Emerging technology index rank
Nanotech Impact factor
SAUDI ARABIA
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
SOUTH AFRICA
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding & Size of Funding Investments
Flagship programs that are in the works/early phase
Emerging technology index rank
Nanotech Impact factor
UNITED KINGDOM
Funding Figures
Policy Changes and Re-focusing
Method of Distribution
Areas of Distribution
Infrastructure Funding
Size of Funding Investments
Flagship programs that are in the works/early phase
Emerging technology index rank
Nanotech Impact factor
ROW
Funding Figures
EMERGING TECHNOLOGY EXPLOITATION INDEX
NANOTECH IMPACT FACTOR INDEX
Sometimes just the raw numbers of public funding for nanotechnology can reveal intriguing trends in how nanotechnology is being developed within a region. These numbers are provided in our Excel Spreadsheet.
However, by looking at the numbers from various angles it opens up the kind of information that can be leveraged for planning and execution. Some of the variables we have consistently looked at over the years to accomplish this have been the following:
- Method of Distribution
- Areas of Distribution
- Infrastructure Funding
- Timescale for Funding
- Size of Funding Investments
The healthcare market is poised to see some of the earliest benefits of nanotechnology. Over the next decade, it will be one of nanotech’s highest growth sectors.
Targeted drug delivery therapies for the treatment of cancer is one of the most commonly cited nano-healthcare benefits. Cientifica’s report, Nanotechnology in Drug Delivery 2011, gives a comprehensive analysis and geographic breakdown of the current nanotechnology drug delivery market and its most relevant technologies. It also provides a forecast for the size of total addressable markets and percent share of those key technologies to 2021.
Some forecasts have predicted the nanotechnology market to reach close to a trillion dollars by 2015, presenting investors with unique opportunities. However, the market for applications of nanotechnology is complex, multidisciplinary and highly segmented. It is therefore essential to gain an understanding of which market sectors nanotechnology is likely to impact most profoundly in the near term.
Since we now know most (if not all) biological processes occur at the nanoscale, the application of life science principles – studying the causes of biological phenomena at the molecular level – means medical and biomedical research is increasingly using a bottom-up (rather than the top-down) approach. The low bioavailability resulting from traditional oral and intravenous drug delivery methods and the market forces at work in the pharmaceutical industry, where patents expire after a relatively short period of time unless a novel form of drug delivery is developed that will extend the patent, are two major forces that will fuel the growth of the nanotech drug delivery market. The third factor at play is a combination of improved global health and a correspondingly dramatic increase in the size of the global aging population.
This report provides insight into the possibilities of targeted nanotech drug delivery and its market potential over the next decade.
AMERICAS
USA
CANADA
ASIA-PACIFIC
AUSTRALIA
CHINA
INDIA
JAPAN
SOUTH KOREA
TAIWAN
EMEA
EC
GERMANY
ISRAEL
RUSSIA
SAUDI ARABIA
SOUTH AFRICA
UK
ROW
22 of the biggest nanotechnology investors from the rest of the world
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
